These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37536263)

  • 1. Discovery and biological evaluation of cholic acid derivatives as potent TGR5 positive allosteric modulators.
    Li Y; Sun J; Wang X; Luo Z; Shao X; Li Y; Cao Q; Zhao S; Qian M; Chen X
    Bioorg Med Chem; 2023 Sep; 92():117418. PubMed ID: 37536263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel cholic acid derivatives as highly potent agonists for G protein-coupled bile acid receptor.
    Qian M; Luo Z; Hou W; Sun J; Lu X; Zhang Q; Wu Y; Xue C; Zhao S; Chen X
    Bioorg Chem; 2022 Mar; 120():105588. PubMed ID: 34979448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical exploration of TGR5 functional hot-spots: Synthesis and structure-activity relationships of C7- and C23-Substituted cholic acid derivatives.
    Rosatelli E; Carotti A; Cerra B; De Franco F; Passeri D; Pellicciari R; Gioiello A
    Eur J Med Chem; 2023 Dec; 261():115851. PubMed ID: 37813065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor.
    Abrigo J; Gonzalez F; Aguirre F; Tacchi F; Gonzalez A; Meza MP; Simon F; Cabrera D; Arrese M; Karpen S; Cabello-Verrugio C
    J Cell Physiol; 2021 Jan; 236(1):260-272. PubMed ID: 32506638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
    Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
    J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly lipophilic 3-epi-betulinic acid derivatives as potent and selective TGR5 agonists with improved cellular efficacy.
    Wang XY; Zhang SY; Li J; Liu HN; Xie X; Nan FJ
    Acta Pharmacol Sin; 2014 Nov; 35(11):1463-72. PubMed ID: 25283506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and characterization of small-molecule TGR5 ligands with agonistic activity.
    Papadopoulos MGE; Perhal AF; Medel-Lacruz B; Ladurner A; Selent J; Dirsch VM; Kolb P
    Eur J Med Chem; 2024 Oct; 276():116616. PubMed ID: 38996653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
    Al Rawashdah S; Hamrouni A; Sadek B; Amer R; Metwaly M; Atatreh N; Ghattas MA
    J Mol Graph Model; 2019 Nov; 92():44-54. PubMed ID: 31306865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Methylation of Chenodeoxycholic Acid Derivatives Yields a Substantial Increase in TGR5 Receptor Potency.
    Nakhi A; McDermott CM; Stoltz KL; John K; Hawkinson JE; Ambrose EA; Khoruts A; Sadowsky MJ; Dosa PI
    J Med Chem; 2019 Jul; 62(14):6824-6830. PubMed ID: 31268316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity.
    Pellicciari R; Gioiello A; Macchiarulo A; Thomas C; Rosatelli E; Natalini B; Sardella R; Pruzanski M; Roda A; Pastorini E; Schoonjans K; Auwerx J
    J Med Chem; 2009 Dec; 52(24):7958-61. PubMed ID: 20014870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5.
    Macchiarulo A; Gioiello A; Thomas C; Massarotti A; Nuti R; Rosatelli E; Sabbatini P; Schoonjans K; Auwerx J; Pellicciari R
    J Chem Inf Model; 2008 Sep; 48(9):1792-801. PubMed ID: 18698841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationships of Pan-Gα
    Berizzi AE; Bender AM; Lindsley CW; Conn PJ; Sexton PM; Langmead CJ; Christopoulos A
    ACS Chem Neurosci; 2018 Jul; 9(7):1818-1828. PubMed ID: 29683647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual Cooperativity of Three Allosteric Sites on the Dopamine D1 Receptor.
    Wang X; Hembre EJ; Goldsmith PJ; Beck JP; Svensson KA; Willard FS; Bruns RF
    Mol Pharmacol; 2023 Mar; 103(3):176-187. PubMed ID: 36804203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of small molecule positive allosteric modulators of the secretin receptor.
    Dengler DG; Harikumar KG; Pollari S; Sun Q; Brown BT; Shinoki-Iwaya A; Ardecky R; Miller LJ; Sergienko EA
    Biochem Pharmacol; 2021 Mar; 185():114451. PubMed ID: 33545115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Biological Evaluation of Covalently Mucoadhesive Derivatives as Nonsystemic Intestine-Targeted TGR5 Agonists.
    Zhao S; Wang L; Huang X; Xiao Y; Li M; Huang X; Chen X; Li S; Xie J; Liu P; Wang YD; Chen WD
    J Med Chem; 2024 Oct; 67(19):17701-17712. PubMed ID: 39321318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects.
    Chaudhari SN; Harris DA; Aliakbarian H; Luo JN; Henke MT; Subramaniam R; Vernon AH; Tavakkoli A; Sheu EG; Devlin AS
    Nat Chem Biol; 2021 Jan; 17(1):20-29. PubMed ID: 32747812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of receptor allosterism and its implication for drug discovery.
    Zhang R; Kavana M
    Expert Opin Drug Discov; 2015 Jul; 10(7):763-80. PubMed ID: 25927503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
    Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists.
    Park EJ; Ahn YG; Jung SH; Bang HJ; Kim M; Hong DJ; Kim J; Suh KH; Kim YJ; Kim D; Kim EY; Lee K; Min KH
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4271-5. PubMed ID: 25082126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.